Pharmacokinetics, Safety, and Biologic Effects of Azithromycin in Extremely Preterm Infants at Risk for Ureaplasma Colonization and Bronchopulmonary Dysplasia

相似書籍

• Azithromycin To Prevent Bronchopulmonary Dysplasia in Ureaplasma-Infected Preterm Infants: Pharmacokinetics, Safety, Microbial Response, and Clinical Outcomes with a 20-Milligram-per-Kilogram Single Intravenous Dose
  由: Viscardi, Rose M., et al.
  出版: (2013)
• Randomised trial of azithromycin to eradicate Ureaplasma in preterm infants
  由: Viscardi, Rose Marie, et al.
  出版: (2020)
• Pharmacokinetics, Microbial Response, and Pulmonary Outcomes of Multidose Intravenous Azithromycin in Preterm Infants at Risk for Ureaplasma Respiratory Colonization
  由: Merchan, L. Marcela, et al.
  出版: (2014)
• Characterization of Ureaplasmas Isolated from Preterm Infants with and without Bronchopulmonary Dysplasia
  由: Katz, Brenda, et al.
  出版: (2005)
• Frequency of Ureaplasma Serovars in Respiratory Secretions of Preterm Infants at Risk for Bronchopulmonary Dsyplasia
  由: SUNG, TAE-JUNG, et al.
  出版: (2011)